The novel therapy of the medication represents a significant development in the care of the condition. Distinct from existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide739220.anchor-blog.com/22416416/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment